Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

The molecular mechanism of chronic myelogenous leukemia and its therapeutic implications: studies in a murine model

Abstract

Chronic myelogenous leukemia (CML) is a malignant disease resulting from the neoplastic transformation of a hematopoietic stem cell. Generation of the BCRABL fusion gene plays an essential role in causing the vast majority of CML. Clinical and laboratory studies have indicated that development of CML involves both the effects of BCR–ABL within its correct target cells and interactions of BCR–ABL target cells with the rest of the in vivo environment, and that the progression of the disease to blast crisis involves multiple genetic alterations. An efficient mouse bone marrow transduction and transplantation model for CML has recently been developed. This review summarizes the analysis of the roles of functional domains and downstream signaling pathways of BCR–ABL, of altered cytokine production, of interferon signaling pathways and of oncogene cooperation in the pathogenesis of CML using this murine model. The in vivo studies of leukemogenesis will help to advance mechanism-based therapies for CML, as well as to understand fundamental rules of leukemogenesis and hematopoiesis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  • Afar DEH, Goga A, McLaughlin J, Witte ON, Sawyers CL . 1994 Science 264: 424–426

  • Ahuja HG, Foti A, Bar-Eli M, Cline MJ . 1990 Blood 75: 1684–1690

  • Ahuja HG, Popplewell L, Tcheurekdjian L, Slovak ML . 2001 Genes Chromosomes Cancer 30: 410–415

  • Bhatia R, Verfaillie CM . 1998 Leuk. Lymphoma 28: 241–254

  • Bonifazi F, de Vivo A, Rosti G, Guilhot F, Guilhot J, Trabacchi E, Hehlmann R, Hochhaus A, Shepherd PC, Steegmann JL, Kluin-Nelemans HC, Thaler J, Simonsson B, Louwagie A, Reiffers J, Mahon FX, Montefusco E, Alimena G, Hasford J, Richards S, Saglio G, Testoni N, Martinelli G, Tura S, Baccarani M . 2001 Blood 98: 3074–3081

  • Bromberg J, Darnell Jr JE . 2000 Oncogene 19: 2468–2473

  • Buchdunger E, Zimmermann J, Mett H, Meyer T, Muller M, Druker BJ, Lydon NB . 1996 Cancer Res. 56: 100–104

  • Carlesso N, Frank DA, Griffin JD . 1996 J. Exp. Med. 183: 811–820

  • Castellanos A, Pintado B, Weruaga E, Arevalo R, Lopez A, Orfao A, Sanchez-Garcia I . 1997 Blood 90: 2168–2174

  • Castilla LH, Wijmenga C, Wang Q, Stacy T, Speck NA, Eckhaus M, Marin-Padilla M, Collins FS, Wynshaw-Boris A, Liu PP . 1996 Cell 87: 687–696

  • Colovic M, Jankovic G, Bila J, Djordjevic V, Wiernik PH . 1998 Med. Oncol. 15: 199–201

  • Cortez D, Kadlec L, Pendergast AM . 1995 Mol. Cell. Biol. 15: 5531–5541

  • Cuenco GM, Nucifora G, Ren R . 2000 Proc. Natl. Acad. Sci. USA 97: 1760–1765

  • Cuenco GM, Ren R . 2001 Oncogene 20: 8236–8248

  • Daley GQ, Van Etten RA, Baltimore D . 1990 Science 247: 824–830

  • Daley GQ, Van Etten RA, Baltimore D . 1991 Proc. Natl. Acad. Sci. USA 88: 11335–11338

  • de Groot RP, Raaijmakers JA, Lammers JW, Jove R, Koenderman L . 1999 Blood 94: 1108–1112

  • Deininger MW, Goldman JM, Melo JV . 2000 Blood 96: 3343–3356

  • Deng M, Daley GQ . 2001 Blood 97: 3491–3497

  • Druker BJ, Sawyers CL, Capdeville R, Ford JM, Baccarani M, Goldman JM . 2001 Hematology (Am. Soc. Hematol. Educ. Program) 87–112

  • Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S, Zimmermann J, Lydon NB . 1996 Nat. Med. 2: 561–566

  • el-Ahmady O, Mansour M, Kamel H, Baker A . 1997 Anticancer Res. 17: 3179–3182

  • Elefanty AG, Cory S . 1992 Mol. Cell. Biol. 12: 1755–1763

  • Elefanty AG, Hariharan IK, Cory S . 1990 EMBO J. 9: 1069–1078

  • Era T, Witte ON . 2000 Proc. Natl. Acad. Sci. USA 97: 1737–1742

  • Faderl S, Talpaz M, Estrov Z, O'Brien S, Kurzrock R, Kantarjian HM . 1999 N. Engl. J. Med. 341: 164–172

  • Frank DA, Varticovski L . 1996 Leukemia 10: 1724–1730

  • Franz WM, Berger P, Wang JYJ . 1989 EMBO J. 8: 137–147

  • Gabriele L, Phung J, Fukumoto J, Segal D, Wang IM, Giannakakou P, Giese NA, Ozato K, Morse III HC . 1999 J. Exp. Med. 190: 411–421

  • Ghaffari S, Daley GQ, Lodish HF . 1999 Leukemia 13: 1200–1206

  • Gishizky ML, Johnson-White J, Witte ON . 1993 Proc. Natl. Acad. Sci. USA 90: 3755–3759

  • Goga A, McLaughlin J, Afar DE, Saffran DC, Witte ON . 1995 Cell 82: 981–988

  • Goldman JM, Druker BJ . 2001 Blood 98: 2039–2042

  • Golub TR, Goga A, Barker GF, Afar DE, McLaughlin J, Bohlander SK, Rowley JD, Witte ON, Gilliland DG . 1996 Mol. Cell. Biol. 16: 4107–4116

  • Gorre ME, Mohammed M, Ellwood K, Hsu N, Paquette R, Rao PN, Sawyers CL . 2001 Science 293: 876–880

  • Griffin JD . 2001 Blood 97: A2193

  • Gross AW, Ren R . 2000 Oncogene 19: 6286–6296

  • Gross AW, Zhang X, Ren R . 1999 Mol. Cell. Biol. 19: 6918–6928

  • Hao SX, Ren R . 2000 Mol. Cell. Biol. 20: 1149–1161

  • Harada H, Taniguchi T, Tanaka N . 1998 Biochimie 80: 641–650

  • Hawley RG . 1994 Ann. NY Acad. Sci. 716: 327–330

  • He Y, Wertheim JA, Xu L, Miller JP, Karnell FG, Choi JK, Ren R, Pear WS . 2002 Blood 99: 2957–2968

  • Heinrich MC, Griffith DJ, Druker BJ, Wait CL, Ott KA, Zigler AJ . 2000 Blood 96: 925–932

  • Heisterkamp N, Jenster G, Kioussis D, Pattengale PK, Groffen J . 1991 Transgenic Research 1: 45–53

  • Heisterkamp N, Jenster G, ten Hoeve J, Zovich D, Pattengale PK, Groffen J . 1990 Nature 344: 251–253

  • Holtschke T, Löhler J, Kanno Y, Fehr T, Giese N, Rosenbauer F, Lou J, Knobeloch K-P, Gabriele L, Waring JF, Bachmann MF, Zinkernagel RM, Morse 3rd HC, Ozato K, Horak I . 1996 Cell 87: 307–317

  • Honda H, Fujii T, Takatoku M, Mano H, Witte ON, Yazaki Y, Hirai H . 1995 Blood 85: 2853–2861

  • Honda H, Oda H, Suzuki T, Takahashi T, Witte ON, Ozawa K, Ishikawa T, Yazaki Y, Hirai H . 1998 Blood 91: 2067–2075

  • Honda H, Ushijima T, Wakazono K, Oda H, Tanaka Y, Aizawa S, Ishikawa T, Yazaki Y, Hirai H . 2000 Blood 95: 1144–1150

  • Huettner CS, Zhang P, Van Etten RA, Tenen DG . 2000 Nature Genetics 24: 57–60

  • Ilaria Jr RL, Van Etten RA . 1995 Blood 86: 3897–3904

  • Ilaria Jr RL, Van Etten RA . 1996 J. Biol. Chem. 271: 31704–31710

  • Jackson P, Baltimore D . 1989 EMBO J. 8: 449–456

  • Janssen JW, Ridge SA, Papadopoulos P, Cotter F, Ludwig WD, Fonatsch C, Rieder H, Ostertag W, Bartram CR, Wiedemann LM . 1995 Br. J. Haematol. 90: 222–224

  • Jiang X, Lopez A, Holyoake T, Eaves A, Eaves C . 1999 Proc. Natl. Acad. Sci. USA 96: 12804–12809

  • Jonuleit T, Peschel C, Schwab R, van der Kuip H, Buchdunger E, Fischer T, Huber C, Aulitzky WE . 1998 Br. J. Haematol. 100: 295–303

  • Kantarjian H, Sawyers C, Hochhaus A, Guilhot F, Schiffer C, Gambacorti-Passerini C, Niederwieser D, Resta D, Capdeville R, Zoellner U, Talpaz M, Druker B . 2002 N. Engl. J. Med. 346: 645–652

  • Kelliher MA, McLaughlin J, Witte ON, Rosenberg N . 1990 Proc. Natl. Acad. Sci. USA 87: 6649–6653

  • Kelliher MA, Weckstein DJ, Knott AG, Wortis HH, Rosenberg N . 1993 Oncogene 8: 1249–1256

  • Kieslinger M, Woldman I, Moriggl R, Hofmann J, Marine JC, Ihle JN, Beug H, Decker T . 2000 Genes Dev. 14: 232–244

  • Landolfo S, Guarini A, Riera L, Gariglio M, Gribaudo C, Cignetti A, Cordone I, Montefusco E, Mandelli F, Foa R . 2000 Hematol. J. 1: 7–14

  • Li S, Gillessen S, Tomasson MH, Dranoff G, Gilliland DG, Van Etten RA . 2001 Blood 97: 1442–1450

  • Li S, Ilaria RL, Million RP, Daley GQ, Van Etten RA . 1999 J. Exp. Med. 189: 1399–1412

  • Matsuyama T, Kimura T, Kitagawa M, Pfeffer K, Kawakami T, Watanabe N, Kundig TM, Amakawa R, Kishihara K, Wakeham A . 1993 Cell 75: 83–97

  • McLaughlin J, Chianese E, Witte ON . 1987 Proc. Natl. Acad. Sci. USA 84: 6558–6562

  • McWhirter JR, Gaalasso DL, Wang JYJ . 1993 Mol. Cell. Biol. 13: 7587–7595

  • Melo JV . 1997 Baillieres Clin. Haematol. 10: 203–222

  • Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, Kaplan DH, Riley JK, Greenlund AC, Campbell D, Carver-Moore K, DuBois RN, Clark R, Aguet M, Schreiber RD . 1996 Cell 84: 431–442

  • Million RP, Van Etten RA . 2000 Blood 96: 664–670

  • Mittrucker HW, Matsuyama T, Grossman A, Kundig TM, Potter J, Shahinian A, Wakeham A, Patterson B, Ohashi PS, Mak TW . 1997 Science 275: 540–543

  • Neubauer A, Dodge RK, George SL, Davey FR, Silver RT, Schiffer CA, Mayer RJ, Ball ED, Wurster-Hill D, Bloomfield CD, Liu ET . 1994 Blood 83: 1603–1611

  • Nguyen H, Hiscott J, Pitha PM . 1998 Cytokine Growth Factor Rev. 8: 293–312

  • Nieborowska-Skorska M, Wasik MA, Slupianek A, Salomoni P, Kitamura T, Calabretta B, Skorski T . 1999 J. Exp. Med. 189: 1229–1242

  • Niki M, Okada H, Takano H, Kuno J, Tani K, Hibino H, Asano S, Ito Y, Satake M, Noda T . 1997 Proc. Natl. Acad. Sci. USA 94: 5697–5702

  • O'Dwyer ME, Druker BJ . 2001 J. Intern. Med. 250: 3–9

  • Oda T, Tamura S, Matsuguchi T, Griffin JD, Druker BJ . 1995 Leukemia 9: 295–301

  • Okuda T, Cai Z, Yang S, Lenny N, Lyu CJ, van Deursen JM, Harada H, Downing JR . 1998 Blood 91: 3134–3143

  • Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR . 1996 Cell 84: 321–330

  • Pane F, Mostarda I, Selleri C, Salzano R, Raiola AM, Luciano L, Saglio G, Rotoli B, Salvatore F . 1999 Blood 94: 2200–2207

  • Pawson T . 1995 Nature 373: 573–580

  • Pear WS, Nolan GP, Scott ML, Baltimore D . 1993 Proc. Natl. Acad. Sci. USA 90: 8392–8396

  • Pear WS, Miller JP, Xu L, Pui JC, Soffer B, Quackenbush RC, Pendergast AM, Bronson R, Aster JC, Scott ML, Baltimore D . 1998 Blood 92: 3780–3792

  • Pendergast AM, Quilliam LA, Cripe LD, Bassing CH, Dai Z, Li N, Batzer A, Rabun KM, Der CJ, Schlessinger J, Gishizky ML . 1993 Cell 75: 175–185

  • Pfeffer LM, Dinarello CA, Herberman RB, William BRG, Borden EC, Bordens R, Walter MR, Nagabhushan TL, Trotta PP, Pestka S . 1998 Cancer Res. 58: 2489–2499

  • Pluk H, Dorey K, Superti-Furga G . 2002 Cell 108: 247–259

  • Ren R . 2002 Leukemia and Lymphoma 8: 1549–1561

  • Rosenberg N, Witte ON . 1988 Advances in virus research Vol. 35 New York: Academic Press, Inc pp 39–81

    Google Scholar 

  • Roumiantsev S, de Aos IE, Varticovski L, Ilaria RL, Van Etten RA . 2001 Blood 97: 4–13

  • Sawyers CL . 1997 Baillieres Clin. Haematol. 10: 223–231

  • Sawyers CL . 2001 Semin. Hematol. 38: 15–21

  • Schmidt M, Hochhaus A, Nitsche A, Hehlmann R, Neubauer A . 2001 Blood 97: 3648–3650

  • Schmidt M, Nagel S, Proba J, Thiede C, Ritter M, Waring JF, Rosenbauer F, Huhn D, Wittig B, Horak I, Neubauer A . 1998 Blood 91: 22–29

  • Sexl V, Piekorz R, Moriggl R, Rohrer J, Brown MP, Bunting KD, Rothammer K, Roussel MF, Ihle JN . 2000 Blood 96: 2277–2283

  • Shuai K, Halpern J, ten Hoeve J, Rao X, Sawyers CL . 1996 Oncogene 13: 247–254

  • Sillaber C, Gesbert F, Frank DA, Sattler M, Griffin JD . 2000 Blood 95: 2118–2125

  • Socolovsky M, Fallon AE, Wang S, Brugnara C, Lodish HF . 1999 Cell 98: 181–191

  • Sood R, Talwar-Trikha A, Chakrabarti SR, Nucifora G . 1999 Leukemia 13: 348–357

  • Talpaz M . 2001 Semin. Hematol. 38: 22–27

  • Tamura T, Nagamura-Inoue T, Shmeltzer Z, Kuwata T, Ozato K . 2000 Immunity 13: 155–165

  • Tanaka T, Mitani K, Kurokawa M, Ogawa S, Tanaka K, Nishida J, Yazaki Y, Shibata Y, Hirai H . 1995 Mol. Cell. Biol. 15: 2383–2392

  • Teglund S, McKay C, Schuetz E, van Deursen JM, Stravopodis D, Wang D, Brown M, Bodner S, Grosveld G, Ihle JN . 1998 Cell 93: 841–850

  • Van Etten RA . 2001 Blood Cells Mol. Dis. 27: 201–205

  • Verfaillie CM, Hurley R, Lundell BI, Zhao C, Bhatia R . 1997 Acta Haematol. 97: 40–52

  • Voncken JW, Griffiths S, Greaves MF, Pattengale PK, Heisterkamp N, Groffen J . 1992 Cancer Res. 52: 4534–4539

  • Voncken JW, Kaartinen V, Pattengale PK, Germeraad WT, Groffen J, Heisterkamp N . 1995 Blood 86: 4603–4611

  • Wang Q, Stacy T, Binder M, Marin-Padilla M, Sharpe AH, Speck NA . 1996 Proc. Natl. Acad. Sci. USA 93: 3444–3449

  • Westendorf JJ, Yamamoto CM, Lenny N, Downing JR, Selsted ME, Hiebert SW . 1998 Mol. Cell. Biol. 18: 322–333

  • Wolff NC, Ilaria Jr RL . 2001 Blood 98: 2808–2816

  • Wong S, Witte ON . 2001 Oncogene 20: 5644–5659

  • Yaish P, Gzit A, Gilon C, Levitzki A . 1988 Science 242: 933–935

  • Yergeau DA, Hetherington CJ, Wang Q, Zhang P, Sharpe AH, Binder M, Marin-Padilla M, Tenen DG, Speck NA, Zhang DE . 1997 Nat. Genet. 15: 303–306

  • Zhang X, Ren R . 1998 Blood 92: 3829–3840

  • Zhang X, Subrahmanyam R, Wong R, Gross AW, Ren R . 2001a Mol. Cell. Biol. 21: 840–853

  • Zhang X, Wong R, Hao SX, Pear WS, Ren R . 2001b Blood 97: 277–287

  • Zhao X, Ghaffari S, Lodish H, Malashkevich VN, Kim PS . 2002 Nat. Struct. Biol. 9: 117–120

  • Zou X, Calame K . 1999 J. Biol. Chem. 274: 18141–18144

Download references

Acknowledgements

I thank Alec W Gross and Ramesh Subrahmanyam for their critical reading of this review. This work was supported by National Cancer Institute grant CA68008 and by ACS Grant RSG-02-059-01-LIB. R Ren is a recipient of The Leukemia and Lymphoma Society Scholar Award.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ruibao Ren.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ren, R. The molecular mechanism of chronic myelogenous leukemia and its therapeutic implications: studies in a murine model. Oncogene 21, 8629–8642 (2002). https://doi.org/10.1038/sj.onc.1206090

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206090

Keywords

This article is cited by

Search

Quick links